Table 1.
UK | Other EU | US | Overall (%) | |
---|---|---|---|---|
Pharmaceutical industry | 4/8 | 3/10 | 8/9 | 15/27 (56%) |
Government regulators | 3/5 | 2/9 | 4/5 | 9/19 (47%) |
Research scientists | 5/10 | 5/8 | 6/8 | 16/26 (62%) |
Other interests groups | 5/9 | 4/6 | 4/6 | 13/21 (62%) |
Overall (%) | 17/32 (53%) | 14/33 (42%) | 22/28 (79%) | 53/93 (57%) |